Silence Therapeutics 13D/A: Major Holder Adds $2.7M, Owns 34.5M Shares
Rhea-AI Filing Summary
Silence Therapeutics Plc (SLN) – Schedule 13D/A Amendment No. 9
The filing discloses the updated beneficial ownership of long-time shareholder Richard Ian Griffiths and several Jersey-based entities he controls. After recent open-market activity and an increase in the company’s share capital, Mr. Griffiths now reports 34,543,302 ordinary shares (held directly and through seven entities), representing 24.4 % of SLN’s 141,690,849 outstanding shares. Voting and dispositive power for all shares is held solely by Mr. Griffiths.
Recent transactions: Between 8 May 2025 and 24 Jun 2025, Mr. Griffiths purchased an additional 543,581 ADSs on the open market for a combined cash consideration of US $2.7 million; each ADS equals three ordinary shares. These purchases were funded with personal or affiliated-company cash.
Entity breakdown:
- Ora Capital Ltd – 19,221,525 ordinary shares (13.6 %)
- Sarossa Plc – 1,815,522 shares
- Cream Capital Ltd – 3,967,896 shares
- Blake Holdings Ltd – 300,000 shares
- Ora Ventures Ltd – 360,000 shares
- Pinkey’s Ltd – 190,500 shares
- Direct holding – 8,687,859 shares
The amendment notes that the percentage ownership has changed because of both the incremental ADS purchases and dilution stemming from a recent increase in the Issuer’s share capital. No new contracts, voting agreements or other material relationships were reported, and a standard joint-filing agreement is included as an exhibit.
Positive
- Insider accumulation: Richard Griffiths purchased 543,581 ADSs for US $2.7 million during May–June 2025, indicating continued confidence.
- Significant holding maintained: Post-transaction ownership stands at 24.4 % of outstanding shares, underscoring sustained long-term commitment.
Negative
- Dilution effect: Percentage ownership declined due to an increase in Silence Therapeutics' share capital, signalling potential dilution for all shareholders.
Insights
TL;DR – Large insider adds US$2.7 m of SLN stock, lifting stake to 24.4 %; signals continued confidence, moderately positive.
The amendment confirms that Richard Griffiths, already SLN’s largest holder, increased exposure by purchasing 543,581 ADSs in May–June 2025. Despite dilution from new share issuance, his ownership remains substantial at 24.4 %. Insider buying of this magnitude (≈US$2.7 m) often supports market sentiment and reduces free float. No leverage or complex financing was used, limiting balance-sheet risk. While the filing does not disclose SLN’s reasons for issuing new shares, the net effect is a modestly positive indicator that a sophisticated investor continues to back the company.
TL;DR – Ownership concentration persists; dilution trims percentage but still above 20 %, governance influence unchanged.
Mr. Griffiths and his controlled entities retain sole voting and dispositive power over more than one-fifth of SLN’s equity, preserving significant governance leverage. The incremental ADS purchases reinforce this position. The filing also highlights an increase in authorised share capital, diluting existing holders—an area investors may scrutinise for future capital-raising discipline. No shareholder agreements or change-of-control intentions are disclosed, keeping the amendment procedural. Overall impact on governance dynamics is neutral: concentration remains high, and no new control mechanisms are introduced.
